Quotient Sciences Acquires Arcinova

Read the press release here

C&EN Article

Following a visit to Alnwick and a tour of Arcinova's facilities, Alex Scott wrote an article in the May 30th 2016 edition of C&EN, outlining the acquisition story and the growth prospects for the business.

He noted that "The firm is off to a promising start" and that "customer loyalty is holding up". He also picked up on the fact that "six or seven" other businesses may be interested in relocating to Alnwick and that the API business is looking very promising.

Finally, Alex concluded with "In a highly competitive field, Arcinova has momentum."

To download the full article, please click on the link below.

Click here to download PDF

Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.